We are live on
!
Find out more
Westfield Capital Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
49.45%
This Fund
S&P 500
This Quarter
Est. Return
+8.45%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.24%
AUM
$12.4B
AUM Growth
+$271M
(+2.2%)
Cap. Flow
-$478M
Cap. Flow
% of AUM
-3.86%
Top 10 Holdings %
Top 10 Hldgs %
16.88%
Holding
289
New
32
Increased
64
Reduced
138
Closed
40
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$127M |
| 2 |
Gilead Sciences
GILD
|
+$125M |
| 3 |
PayPal
PYPL
|
+$89.3M |
| 4 |
UnitedHealth
UNH
|
+$88.1M |
| 5 |
GE Aerospace
GE
|
+$81.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$148M |
| 2 |
Kroger
KR
|
+$105M |
| 3 |
Costco
COST
|
+$94.8M |
| 4 |
Lam Research
LRCX
|
+$79.3M |
| 5 |
Charter Communications
CHTR
|
+$73.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.46% |
| 2 | Technology | 16.23% |
| 3 | Industrials | 15.74% |
| 4 | Consumer Discretionary | 11.32% |
| 5 | Communication Services | 10.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Nice
NICE
$6.05B
| $25.6M | 0.21% |
381,993
-9,375
| -2% | -$624K |
|
152
Western Alliance Bancorporation
WAL
$9.2B
| $25.3M | 0.2% |
+673,175
| New | +$23.9M |
|
|
CYBR
153
DELISTED
CyberArk
CYBR
| $25.2M | 0.2% |
507,470
+18,020
| +4% | +$959K |
|
|
ORBK
154
DELISTED
Orbotech Ltd
ORBK
| $24.9M | 0.2% |
840,290
+196,395
| +31% | +$5.57M |
|
155
Hasbro
HAS
$12.9B
| $24M | 0.19% |
+302,900
| New | +$24.6M |
|
156
Hexcel
HXL
$7.88B
| $24M | 0.19% |
541,016
-16,105
| -3% | -$705K |
|
|
ANDV
157
DELISTED
Andeavor
ANDV
| $23.7M | 0.19% |
+297,510
| New | +$22.9M |
|
158
Rush Enterprises Class A
RUSHA
$6.43B
| $23.4M | 0.19% |
2,155,144
-582,372
| -21% | -$5.98M |
|
159
Ulta Beauty
ULTA
$23.4B
| $23.3M | 0.19% |
98,007
-173,796
| -64% | -$43.9M |
|
160
Dollar General
DG
$28.1B
| $22.7M | 0.18% |
323,815
-85,980
| -21% | -$7.28M |
|
|
SAVE
161
DELISTED
Spirit Airlines, Inc.
SAVE
| $22.7M | 0.18% |
532,900
-14,280
| -3% | -$592K |
|
|
NORD
162
DELISTED
Nord Anglia Education, Inc.
NORD
| $22.3M | 0.18% |
1,025,600
-4,365
| -0.4% | -$95.6K |
|
|
SUM
163
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $22.3M | 0.18% |
1,255,367
+131,198
| +12% | +$2.54M |
|
164
MasTec
MTZ
$21.8B
| $22.3M | 0.18% |
748,926
+255,175
| +52% | +$7M |
|
165
Dave & Buster's
PLAY
$369M
| $21.7M | 0.18% |
554,450
-13,440
| -2% | -$595K |
|
|
AMWD
166
DELISTED
American Woodmark
AMWD
| $21.2M | 0.17% |
262,878
+14,590
| +6% | +$1.14M |
|
|
CHUY
167
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $21.2M | 0.17% |
757,515
+395,241
| +109% | +$12.7M |
|
|
ARRS
168
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $20.7M | 0.17% |
729,335
-361,125
| -33% | -$9.65M |
|
169
Commault Systems
CVLT
$5.47B
| $20.5M | 0.17% |
385,037
-70,510
| -15% | -$3.54M |
|
170
Cullen/Frost Bankers
CFR
$10.5B
| $19.7M | 0.16% |
273,256
-7,745
| -3% | -$536K |
|
171
HEICO Corp Class A
HEI.A
$37.2B
| $19.2M | 0.16% |
620,244
-16,465
| -3% | -$480K |
|
172
Omnicell
OMCL
$1.69B
| $18.8M | 0.15% |
491,816
+252,545
| +106% | +$9.42M |
|
173
BioMarin Pharmaceuticals
BMRN
$11.7B
| $18.6M | 0.15% |
+201,575
| New | +$19M |
|
174
MarketAxess Holdings
MKTX
$5.71B
| $18.6M | 0.15% |
112,411
+4,141
| +4% | +$672K |
|
175
CBRE Group
CBRE
$43.7B
| $18.5M | 0.15% |
661,118
-453,630
| -41% | -$12.9M |
|
Similar funds
OAG
JG
CHP
SC
Westfield Capital Management's Q3 2016 Portfolio in Review
As of Q3 2016, Westfield Capital Management held 289 positions worth $12.4B, up 2.2% from $12.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Westfield Capital Management withdrew a net $478M in Q3 2016, closing 40 positions and reducing 138 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $148M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Industrials.
Against the trend, Westfield Capital Management opened a new position in Abbott worth $126M.
- Westfield Capital Management's largest Q3 2016 buy was Abbott: 2,973,638 shares worth $126M.
- Westfield Capital Management added most to UnitedHealth in Q3 2016, an estimated $88.1M increase.
- Westfield Capital Management's biggest Q3 2016 reduction was Costco, cutting an estimated $94.8M.
- Westfield Capital Management fully exited Teva Pharmaceuticals in Q3 2016, selling an estimated $148M.
- Westfield Capital Management's ten largest holdings make up 17% of its $12.4B portfolio in Q3 2016.
- Westfield Capital Management opened 32 new positions and closed 40 in Q3 2016.
- Westfield Capital Management's portfolio value rose 2.2% quarter-over-quarter to $12.4B.
Based on Westfield Capital Management's 13F filing for Q3 2016, filed 10 Nov 2016.